NCT07136870

Brief Summary

The purpose of this exploratory study is to assess the adhesive forces to skin of samples over the period of 24 hours to establish the peel-off measurement method at the Essity study site.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2026

Completed
Last Updated

September 2, 2025

Status Verified

August 1, 2025

Enrollment Period

1 month

First QC Date

August 15, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

Tape adhesionAdhesion residues on skinTape removal sensation degreemedical tapeswide area fixationPost-Operative dressings

Outcome Measures

Primary Outcomes (2)

  • Adhesion

    Medical tape sample's adhesion force to skin measured in Newton-centimeter

    After 24 hours of tape use

  • Adhesive forces measured in N/cm

    1-2 months

Study Arms (1)

Experimental Group Tape wearing

EXPERIMENTAL

Sixteen samples of different test materials (medical tape) will be placed on the participant's upper and lower back. This ingle group acts as it's own control.

Device: Medical tape

Interventions

The purpose of this exploratory study is to assess the adhesion to skin properties of test material samples over 24 hours to establish the peel-off measurement method at the new Essity study site. As the performance and safety of the tapes, WAFs and post-OPs in its intended use are not tested in the current study it is not considered a medical device study according to EU medical device regulation (MDR) 2017/745

Also known as: Leukosilk tape, Fixomull stretch, wide area fixation tape, Fixomull skin sensitive, wide area fixation tape, Leukoplast tape, Fixomull transparent, wide area fixation tape, Leukopor tape, Leukomed, post-operative tape, Leukomed T skin sensitive, post-operative tape
Experimental Group Tape wearing

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The participants must meet all of the following criteria to be eligible to participate in the investigation:
  • Written informed consent to participate in the study.
  • Willingness to actively participate in the study and to come to the scheduled visits.
  • Female and/or male.
  • From 18 to 70 years of age.
  • Minimal hairiness on the back (the test area)

You may not qualify if:

  • Participants meeting any of the following criteria will not be permitted to participate in the investigation:
  • Female participants: Pregnancy or lactation.
  • Drug or alcohol addiction.
  • AIDS, HIV-positive or infectious hepatitis.
  • Conditions which exclude a participation or might influence the test reaction/evaluation.
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area.
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years.
  • Diabetes mellitus (type 1 and 2).
  • Active skin disease at the test area.
  • Documented allergies to dressings in particular with acrylates and natural rubber (latex).
  • Wounds, moles, tattoos, scars, irritated skin at the test area that could influence the investigation.
  • Any topical medication at the test area within the last 24 hours prior to the start of the study and/or throughout the entire course of the study.
  • Application of cosmetics (e.g. creams, lotions, sunscreens) to the test area within the last 3 days prior to start of the study.
  • Showering at the day of study start.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Essity Study Site

Mölndal, VGR, 43131, Sweden

Location

Central Study Contacts

Shabira Abbas Senior Scientist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: * Exploratory * Intra-individual comparison * Coded test samples
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2025

First Posted

August 22, 2025

Study Start

September 1, 2025

Primary Completion

October 1, 2025

Study Completion

February 11, 2026

Last Updated

September 2, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

IPD data will be only used internally by Essity and not be shared with other researchers.

Locations